FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891740918> ?p ?o ?g. }

• W2891740918 abstract "Abstract Melanoma is a highly immunogenic tumor with a good response to treatment with immune checkpoint inhibitors. Tumor-associated macrophages (TAMs) play an important immunosuppressive role in such tumors and have therefore been identified as possible future therapeutic targets in oncology. The aim of this study was to identify novel immunoregulatory receptors specifically expressed on TAM. Expression of Slamf9, a member of the signaling lymphocytic-activating molecule (Slam) immunoreceptor family, was found to be upregulated in a gene expression analysis of murine bone marrow-derived macrophages (BMDM) stimulated with tumor-conditioned medium of B16F1 melanoma cells. SLAMF9 + macrophages were identified in human and murine melanomas by using self-generated antibodies against human and murine SLAMF9. A comprehensive immunohistochemical analysis of tissue microarrays detected SLAMF9 + TAM in 73.3% of human melanomas, but also in 95.5% of naevi of melanoma patients and in 50% of naevi from healthy controls. In addition, 20% of melanomas and 2.3% of naevi from melanoma patients displayed a positive SLAMF9 expression also in melanocytic cells. No SLAMF9 expression was detected in naevus cells of healthy donors. Although SLAMF9 has no intracellular signaling motif, a comprehensive functional analysis revealed that the molecule was able to significantly enhance TNF-α secretion after LPS-stimulation. In addition, SLAMF9 delayed the wound closure of RAW 264.7 cells in a scratch assay, while proliferation and cell death were not affected. Taken together, SLAMF9 is a novel type-I-transmembrane receptor with immunomodulatory properties in macrophages. Further studies are required to evaluate whether SLAMF9 classifies as a promising future therapeutic target in melanoma." @default.
• W2891740918 created "2018-09-27" @default.
• W2891740918 creator A5006621588 @default.
• W2891740918 creator A5012842259 @default.
• W2891740918 creator A5018101422 @default.
• W2891740918 creator A5028943756 @default.
• W2891740918 creator A5044905497 @default.
• W2891740918 creator A5055252208 @default.
• W2891740918 creator A5058960315 @default.
• W2891740918 creator A5068534763 @default.
• W2891740918 creator A5081965579 @default.
• W2891740918 creator A5085692840 @default.
• W2891740918 date "2018-09-19" @default.
• W2891740918 modified "2023-10-14" @default.
• W2891740918 title "The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration" @default.
• W2891740918 cites W1535240987 @default.
• W2891740918 cites W1641067856 @default.
• W2891740918 cites W1956969176 @default.
• W2891740918 cites W1999995687 @default.
• W2891740918 cites W2004040654 @default.
• W2891740918 cites W2007265067 @default.
• W2891740918 cites W2014421526 @default.
• W2891740918 cites W2014472703 @default.
• W2891740918 cites W2018669781 @default.
• W2891740918 cites W2022428562 @default.
• W2891740918 cites W2029776744 @default.
• W2891740918 cites W2036821908 @default.
• W2891740918 cites W2046752806 @default.
• W2891740918 cites W2057149060 @default.
• W2891740918 cites W2064081167 @default.
• W2891740918 cites W2071752467 @default.
• W2891740918 cites W2072325701 @default.
• W2891740918 cites W2092921437 @default.
• W2891740918 cites W2106637648 @default.
• W2891740918 cites W2122510983 @default.
• W2891740918 cites W2132861582 @default.
• W2891740918 cites W2146685446 @default.
• W2891740918 cites W2156641622 @default.
• W2891740918 cites W2187766800 @default.
• W2891740918 cites W2279890691 @default.
• W2891740918 cites W2297315647 @default.
• W2891740918 cites W2395062256 @default.
• W2891740918 cites W2531617746 @default.
• W2891740918 cites W2566414030 @default.
• W2891740918 cites W2590692536 @default.
• W2891740918 cites W2592502679 @default.
• W2891740918 cites W2614450485 @default.
• W2891740918 cites W2688650891 @default.
• W2891740918 cites W79143732 @default.
• W2891740918 doi "https://doi.org/10.1038/s41419-018-1011-1" @default.
• W2891740918 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6145869" @default.
• W2891740918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30232321" @default.
• W2891740918 hasPublicationYear "2018" @default.
• W2891740918 type Work @default.
• W2891740918 sameAs 2891740918 @default.
• W2891740918 citedByCount "15" @default.
• W2891740918 countsByYear W28917409182019 @default.
• W2891740918 countsByYear W28917409182020 @default.
• W2891740918 countsByYear W28917409182021 @default.
• W2891740918 countsByYear W28917409182022 @default.
• W2891740918 countsByYear W28917409182023 @default.
• W2891740918 crossrefType "journal-article" @default.
• W2891740918 hasAuthorship W2891740918A5006621588 @default.
• W2891740918 hasAuthorship W2891740918A5012842259 @default.
• W2891740918 hasAuthorship W2891740918A5018101422 @default.
• W2891740918 hasAuthorship W2891740918A5028943756 @default.
• W2891740918 hasAuthorship W2891740918A5044905497 @default.
• W2891740918 hasAuthorship W2891740918A5055252208 @default.
• W2891740918 hasAuthorship W2891740918A5058960315 @default.
• W2891740918 hasAuthorship W2891740918A5068534763 @default.
• W2891740918 hasAuthorship W2891740918A5081965579 @default.
• W2891740918 hasAuthorship W2891740918A5085692840 @default.
• W2891740918 hasBestOaLocation W28917409181 @default.
• W2891740918 hasConcept C134018914 @default.
• W2891740918 hasConcept C159654299 @default.
• W2891740918 hasConcept C170493617 @default.
• W2891740918 hasConcept C203014093 @default.
• W2891740918 hasConcept C2777658100 @default.
• W2891740918 hasConcept C2778690821 @default.
• W2891740918 hasConcept C49039625 @default.
• W2891740918 hasConcept C502942594 @default.
• W2891740918 hasConcept C55493867 @default.
• W2891740918 hasConcept C71924100 @default.
• W2891740918 hasConcept C86803240 @default.
• W2891740918 hasConcept C8891405 @default.
• W2891740918 hasConceptScore W2891740918C134018914 @default.
• W2891740918 hasConceptScore W2891740918C159654299 @default.
• W2891740918 hasConceptScore W2891740918C170493617 @default.
• W2891740918 hasConceptScore W2891740918C203014093 @default.
• W2891740918 hasConceptScore W2891740918C2777658100 @default.
• W2891740918 hasConceptScore W2891740918C2778690821 @default.
• W2891740918 hasConceptScore W2891740918C49039625 @default.
• W2891740918 hasConceptScore W2891740918C502942594 @default.
• W2891740918 hasConceptScore W2891740918C55493867 @default.
• W2891740918 hasConceptScore W2891740918C71924100 @default.
• W2891740918 hasConceptScore W2891740918C86803240 @default.
• W2891740918 hasConceptScore W2891740918C8891405 @default.
• W2891740918 hasFunder F4320320879 @default.
• W2891740918 hasIssue "10" @default.
• W2891740918 hasLocation W28917409181 @default.

• next